Shots:
The US FDA has granted FTD to ADCE-D01 for the treatment of soft tissue sarcoma (STS)
ADCE-D01 is being evaluated in P-I/II (ADCElerate1/EUCT) dose escalation & expansion study as a monotx. for metastatic &/or unresectable STS, with enrolment ongoing in the US & EU
ADCE-D01 is an ADC targeting uPARAP & conjugated to the…
